Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DuPont de Nemours, Inc. Common Stock (NY:DD)

76.78 -0.39 (-0.51%)
Official Closing Price Updated: 4:10 PM EDT, Sep 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about DuPont de Nemours, Inc. Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Why Rogers Stock Tanked Again on Thursday
Investors are really taking the cancellation of the DuPont deal hard. 
Via The Motley Fool
Check Out What Whales Are Doing With DuPont de Nemours
A whale with a lot of money to spend has taken a noticeably bearish stance on DuPont de Nemours. Looking at options history for DuPont de Nemours (NYSE:DD) we detected 28 strange trades. 
Via Benzinga
Why Rogers Stock Crashed Hard Today
Chemicals giant DuPont was waiting for one final regulatory approval of its pending Rogers buyout, but that hurdle was never cleared. 
Via The Motley Fool
Why Is Rogers Corporation (ROG) Stock Down 44% Today?
Rogers Corporation (ROG) stock is falling hard on Wednesday following confirmation that DuPont (DD) no longer plans to acquire the company. 
Via InvestorPlace
Downsizing At Twitter After Musk Takeover, Big Pharma Chains To Pay $14B In Opioid Claims, Tesla Shutters 1st Showroom In China: Top Stories Wednesday, Nov. 02
Reuters 
Via Benzinga
Expert Ratings for DuPont de Nemours
Within the last quarter, DuPont de Nemours (NYSE:DD) has observed the following analyst ratings: 
Via Benzinga
Analyst Ratings for DuPont de Nemours
Within the last quarter, DuPont de Nemours (NYSE:DD) has observed the following analyst ratings: 
Via Benzinga
8 Analysts Have This to Say About DuPont de Nemours
Analysts have provided the following ratings for DuPont de Nemours (NYSE:DD) within the last quarter: 
Via Benzinga
DuPont - Rogers $5.2B Deal Loses Out To Regulatory Hurdles
 
Via Benzinga
Jim Cramer Likes This Biotechnology Stock: 'It's Not Big, But It's Not Bad'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes Royalty Pharma plc (NASDAQ: RPRX) and will stick with it. "It’s not big, but it’s not bad," he added. 
Via Benzinga
2 High-Yield Dividend Stocks That Are Passive Income Powerhouses
Investing in equal parts of Chevron and Dow produces a dividend yield above 5%. 
Via The Motley Fool
This Dirt-Cheap High-Yield Dow Jones Stock Is a Screaming Buy
Dow is a blue-chip chemicals company that is trading at its cheapest valuation and offers its highest dividend yield in years. 
Via The Motley Fool
RBC Capital Maintains Outperform Rating for DuPont de Nemours: Here's What You Need To Know
RBC Capital has decided to maintain its Outperform rating of DuPont de Nemours (NYSE:DD) and lower its price target from $75.00 to $71.00. Shares of DuPont de Nemours are trading down 4.13% over the... 
Via Benzinga
Where DuPont de Nemours Stands With Analysts
Analysts have provided the following ratings for DuPont de Nemours (NYSE:DD) within the last quarter: 
Via Benzinga
2 Dividend Stocks The Activist Investor Behind Disney Has Also Been Buying
Activist investor Dan Loeb is the Chief Executive Officer and founder of hedge fund Third Point Management, which has recently opened a stake in The Walt Disney Company (NYSE: DIS) of 1,000,000... 
Via Benzinga
This Electric Toothbrush Has 6 Cleaning Modes For Reportedly Brighter Smiles
This Electric Toothbrush Has 6 Cleaning Modes For Reportedly Brighter Smiles 
Via News Direct
This Electric Toothbrush Has 6 Cleaning Modes For Reportedly Brighter Smiles
Toothbrushes have come a long way since Babylonians and Egyptians started brushing their teeth with frayed twigs around 3000 BCE.  
Via Benzinga
7 Blue-Chip Stocks That Will Survive 2022
These are among the best blue-chip stocks to buy now. Here's why ABBV, BDX, CI, DD, MMM, JPM, and PFE can make great investments. 
Via InvestorPlace
Morgan Stanley Maintains Equal-Weight Rating for DuPont de Nemours: Here's What You Need To Know
Morgan Stanley has decided to maintain its Equal-Weight rating of DuPont de Nemours (NYSE:DD) and lower its price target from $93.00 to $72.00. Shares of DuPont de Nemours are trading down 1.57% over... 
Via Benzinga
Second Quarter Earnings Season: Consumer Discretionary Sector Holds Up Despite Recession Concerns
As we are in the heart of the earnings season, 56% of companies in the S&P 500 have reported second quarter earnings, according to FactSet. Companies are so far reporting earnings that are 3.1%  above... 
Via Benzinga
DuPont Revises Annual Guidance, Trails Wall Street Estimates, Shares Tick Lower
DuPont de Nemours Inc (NYSE: DD) Q2 sales increased 7% Y/Y to $3.3 billion, missing the consensus of $4.2 billion. 
Via Benzinga
Recap: DuPont de Nemours Q2 Earnings
  DuPont de Nemours (NYSE:DD) reported its Q2 earnings results on Tuesday, August 2, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
DuPont de Nemours Earnings Conference Call Is Coming Up, Here's What You Need To Know
DuPont de Nemours (NYSE:DD) will host a conference call at 08:00 AM ET on August 2, 2022, to discuss Q2 2022 earnings results. How to Attend DuPont de Nemours (DD) Conference Call Follow this link to... 
Via Benzinga
Mastercard to $425? Plus Raymond James Predicts $2,350 For This Stock
JP Morgan cut the price target on Mastercard Incorporated (NYSE: MA) from $430 to $425. Mastercard shares fell 0.7% to $338.12 in pre-market trading. 
Via Benzinga
7 Best Defense Stocks to Buy Now
These are seven of the best defense stocks that offers massive potential upside to ride the current industry tailwinds. 
Via InvestorPlace
This Company Says It Has Set Its Sights High To Make A Continued Splash In The Specialty Beverage Market
Demand for convenience food and beverages and increasing concerns from consumers about what they’re ingesting are reportedly driving growth in the specialty food and beverage market.  Data Bridge... 
Via Benzinga
7 Overlooked Blue-Chip Stocks to Add to Your Buy List
With investors seeking viable ideas during this strange time, overlooked blue-chip stocks to buy could offer stable contrarian upside. 
Via InvestorPlace
Stretched to the Max, Shandong Ruyi Loses Control of Lycra
Key Takeaways: Three and a half years after spending $2.6 billion to buy 53% of Lycra, Shandong Ruyi has lost control of the fashion brand after creditors seized a majority of... 
Via Benzinga
Where DuPont de Nemours Stands With Analysts
Over the past 3 months, 6 analysts have published their opinion on DuPont de Nemours (NYSE:DD) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 16, 2022
Upgrades 
Via Benzinga
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.